Atrial fibrillation: Rhythm or rate control?

HeartDrug

Volumn 3, Issue 3, 2003, Pages 164-170

  Landolina, Maurizio ^a   De Ferrari, Gaetano M ^a   Cantù, Francesco ^a   Petracci, Barbara ^a   Tavazzi, Luigi ^a  

^a FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

Author keywords

Antiarrhythmic drugs; Anticoagulation; Atrial fibrillation; Heart failure

Indexed keywords

CARDIOVERSION; COMPARATIVE STUDY; DATA ANALYSIS; DISEASE COURSE; FOLLOW UP; HAZARD ASSESSMENT; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART RHYTHM; HUMAN; POPULATION; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK; SINUS RHYTHM;

EID: 0344364565     PISSN: 14229528     EISSN: None     Source Type: Journal    
DOI: 10.1159/000072741     Document Type: Review

References (29)

1. Kopecky SL, Gersh BJ, McGoon MD, Whisnant JP, Holmes DR Jr, Ilstrup DM, Frye RL: The natural history of lone atrial fibrillation: A population-based study over three decades. N Engl J Med 1987;317:669-674.
2. Wellens HJJ: Atrial fibrillation - the last big hurdle in treating supraventricular tachycardia. N Engl J Med 1994;331:944-945.
3. Petersen P, Godtfredsen J: Embolic complications in paroxysmal atrial fibrillation. Stroke 1986;17:622-626.
4. Benjamin EJ, Wolf PA, D'Agostino RB, Silbershatz H, Kannel WB, Levy D: Impact of atrial fibrillation on the risk of death: The Framing-ham Heart Study. Circulation 1998;98:946-952.
5. Wolf PA, Mitchell JB, Baker CS, Kannel WB, D'Agostino RB: Impact of atrial fibrillation on mortality, stroke, and medical costs. Ann Intern Med 1998;158:229-234.
6. Levy S, Breithardt G, Campbell RWF, Camm AJ, Daubert JC, Allessie M, Aliot E, Caspucci A, Cosio F, Crijins H, Jordaens L, Hauer RN, Lombardi F, Luderitz B: Atrial fibrillation: Current knowledge and recommendations for management. Eur Heart J 1998;19:1294-1320.
7. ACC/AHA/ESC Guidelines for the management of patients with atrial fibrillation: Executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients with Atrial Fibrillation) developed in collaboration with the North American Society of Pacing and Electrophysio-logy. Circulation 2001;104:2118-2150.
8. Konings KT, Kirchhof CJ, Smeets JR, Wellens HJ, Penn OC, Allessie MA: High-density mapping of electrically induced atrial fibrillation in humans. Circulation 1994;89:1665-1680.
9. Haissaguerre M, Jais P, Shah DC, Takahashi A, Hocini M, Quiniou G, Garrigue S, Le Mouroux A, Le Metayer P, Clementy J: Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med 1998;339:659-666.
10. Jais P, Hocini M, Macle L, Choi KJ, Deisenhofer I, Weerasooriya R, Shah DC, Garrigue S, Raybaund F, Scavee C, Le Metayer P, Clementy J, Haissaguerre M: Distinctive electrophysiological properties of pulmonary veins in patients with atrial fibrillation. Circulation 2002; 106:2479-2485.
11. Schauerte P, Scherlag B, Patterson E, Scherlag MA, Matsudaria K, Nakagawa H, Lazzara R, Jackman WM: Focal atrial fibrillation: Experimental evidence for a pathophysiologic role of the autonomic nervous system. J Cardiovasc Electrophysiol 2001;12:592-599.
12. Wijffels MCEF, Kirchhof CJHJ, Dorland R, Allessie MA: Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats. Circulation 1995;92:1954-1968.
13. Waldo AL: Management of atrial fibrillation: The need for AFFIRMative action. Am J Cardiol 1999;84:698-700.
14. Hart RG, Benavente O, McBride R, Pearce LA: Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: A meta-analysis. Ann Intern Med 1999;131:492-501.
15. Nattel S, Hadjis T, Talajic M: The treatment of atrial fibrillation: An evaluation of drug therapy, electrical modalities and therapeutic considerations. Drugs 1994;48:345-371.
16. Ganz LI, Antman EM: Antiarrhythmic drug therapy in the management of atrial fibrillation. J Cardiovasc Electrophysiol 1997;8:1175-1189.
17. Prystowsky EN: Proarrhythmia during drug treatment of supraventricular tachycardia: Paradoxical risk of sinus rhythm for sudden death. Am J Cardiol 1996;78:35-41.
18. Hohnloser SH, Kuck KH, Lilienthal J, for the PIAF Investigators: Rhythm or rate control in atrial fibrillation - Pharmacological Intervention in Atrial Fibrillation (PIAF): A randomized trial. Lancet 2000;356:1789-1794.
19. The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) Investigators: A comparison of rate control and rhythm control in patients with atrial fibrillation. N Engl J Med 2002;347:1825-1833.
20. Van Gelder IC, Hegens VE, Bosker HA, Kingma JH, Kamp O, Kingma T, Said SA, Darmanata JI, Timmermans AJM, Tijssen JGP, Crijns HJGM, for the Rate Control versus Electrical Cardioversion for Persistent Atrial Fibrillation Study Group: A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. N Engl J Med 2002; 347:1834-1840.
21. Reiffel JA: Impact of structural heart disease on the selection of class III antiarrhythmics for the prevention of atrial fibrillation and flutter. Am Heart J 1998;135:551-556.
22. Benjamin EJ, Levy D, Vaziri SM, D'Agostino RB, Belanger AJ, Wolf PA: Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study. JAMA 1994;271:840-844.
23. De Ferrari GM, Tavazzi L: The role of arrhythmias in the progression of heart failure. Eur J Heart Fail 1999;1:35-40.
24. Opasich C, Febo O, Riccardi PG, Traversi E, Forni G, Pinna G, Pozzoli M, Riccardi R, Mortara A, Sanarico M, Cobelli F, Tavazzi L: Concomitant factors of decompensation in chronic heart failure. Am J Cardiol 1996;78:354-357.
25. Stevenson WG, Stevenson LW, Middlekauff HR, Hamilton MA, Natterson PD, Tillisch JH: Improving survival for patients with atrial fibrillation and advanced heart failure. J Am Coll Cardiol 1996;28:1458-1463.
26. Van den Berg MP, Van Gelder IC, Van Veldhuisen DJ: Impact of atrial fibrillation on mortality in patients with chronic heart failure. Eur J Heart Fail 2002;4:571-575.
27. Van den Berg MP, Tuinenburg AE, Crijns HJGM, van Gelder IC, Gosseling ATM, Lie KI: Heart failure and atrial fibrillation: Current concepts and controversies. Heart 1997;77:309-313.
28. Landolina M, De Ferrari GM, Cantù F, Casella M, Petracci B, Moretti P, Piasani A, Campana C, Lanzarini L: Internal cardioversion of permanent atrial fibrillation in patients with severe heart failure: One year follow-up (abstract). Eur Heart J 2001;22:562.
29. The AF-CHF Trial Investigators: Rationale and design of a study assessing treatment strategies of atrial fibrillation in patients with heart failure: The Atrial Fibrillation and Congestive Heart Failure (AF-CHF) trial. Am Heart J 2002;144:597-607.